Search Results 1091-1100 of 3286 for backwatersare

  1. Prospective, Multi-center, Single-arm, Observational Study. US FDA 522 Pediatric Post Market Surveillance Study. - Mayo Clinic

    The purpose of this post-market surveillance study is to capture data on children who undergo CRRT using the Carpediem™ system. Participating clinicians will ...

  2. Arteriovenous malformation - Doctors and departments - Mayo Clinic

    In this condition, a tangle of blood vessels affects the flow of blood and oxygen. Treatment can help.

  3. Publications - Karine Shebaclo, M.D. - Mayo Clinic

    Liu K, Valentini C, Limage K, Moss H, Whitlark A, Cheng T, Bair H, Marous C, Flanders A, Rosen M, Nyquist G, Toskala E, Shebaclo K, Watson A, Rabinowitz M.

  4. Arteriovenous malformation - Doctors and departments - Mayo Clinic

    In this condition, a tangle of blood vessels affects the flow of blood and oxygen. Treatment can help.

  5. Arteriovenous malformation - Doctors and departments - Mayo Clinic

    In this condition, a tangle of blood vessels affects the flow of blood and oxygen. Treatment can help.

  6. Arteriovenous malformation - Doctors and departments - Mayo Clinic

    In this condition, a tangle of blood vessels affects the flow of blood and oxygen. Treatment can help.

  7. Arteriovenous malformation - Doctors and departments - Mayo Clinic

    In this condition, a tangle of blood vessels affects the flow of blood and oxygen. Treatment can help.

  8. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

    Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast ...

  9. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

    A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early ...

  10. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...